Prime Medicine, Inc. (NASDAQ: PRME) Stock Information | RedChip

Prime Medicine, Inc. (NASDAQ: PRME)


$2.9200
-0.2300 ( -6.11% ) 522.0K

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Market Data


Open


$2.9200

Previous close


$3.1500

Volume


522.0K

Market cap


$392.83M

Day range


$2.9000 - $3.1750

52 week range


$2.5600 - $9.7700

SEC Filings


Form Type Description Pages Date
10-k Annual reports 115 Mar 01, 2024
3 Insider transactions 1 Feb 29, 2024
4 Insider transactions 1 Feb 27, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 1 Feb 20, 2024
4 Insider transactions 1 Feb 20, 2024

Latest News